University of Wisconsin, Milwaukee
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Milwaukee sits in the top decile of US sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count).
University of Wisconsin, Milwaukee: 21 sponsored US clinical trials, 4 recruiting.
University of Wisconsin, Milwaukee sponsors 21 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 15 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Tic Disorders, with 1 trials.
Top-decile sponsor footprint
University of Wisconsin, Milwaukee ranks in the top decile of sponsors by registered trial count (#714 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
15 of 17 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
21 total, page 1 of 1
Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Water
NCT05736302
Neural Mechanisms of Response Inhibition Training for OCRD
NCT05377125
Attention Bias Modification Training for Social Phobia (ABMSP)
NCT06054386
EMST in Patients Undergoing CRT for HNCA
NCT03916809
Breathing Room Intervention to Achieve Better Lung Health in Older Adults
NCT05330780
EMST and Swallowing in Long-Term Survivors of HNCA
NCT03975465
Skin Picking Approach Avoidance Task
NCT04099537
Step-Up Intervention for Self-Management of Fatigue in Young Adults Receiving Chemotherapy
NCT03000166
Cognitive Bias Modification for Thought-Action Fusion
NCT03921255
Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania
NCT02059980
Interpretive Biases in Children With Social Anxiety
NCT02219243
Response Inhibition Training for Children With Williams Syndrome
NCT02212314
Online Response Inhibition Training for Trichotillomania
NCT01984333
VoIP Delivered Behavior Therapy for Tourette Syndrome
NCT02247206
Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV Risk
NCT01510262
Developing Cognitive Training for Tourette Syndrome
NCT01440023
Biomechanical Assessment of Gait in Lower-Extremity-Amputees
NCT01332123
Response Inhibition Training for Individuals With Trichotillomania
NCT01638975
Resistance Training to Improve Physical Function in the Elderly
NCT01385475
Testing a New Therapy for Trichotillomania
NCT00872742
Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy
NCT00612443
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
What is open in the University of Wisconsin, Milwaukee pipeline
4 recruiting of 21 indexed (19% open); 15 completed (71%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Chronic Tic Disorders (1 trial), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Milwaukee: open-pipeline peers nationwide
Peers matched on 21 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Milwaukee sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 21 trials (± recruiting share)
- AEterna Zentaris · 21 trials · 0% recruiting
- Amphastar Pharmaceuticals · 21 trials · 5% recruiting
- Apellis Pharmaceuticals · 21 trials · 10% recruiting
- Array Biopharma, now a wholly owned subsidiary of Pfizer · 21 trials · 0% recruiting
Sponsors near 19% open enrollment (± trial volume)
- MemorialCare Health System · 19% recruiting · 21 trials
- University of North Texas Health Science Center · 19% recruiting · 21 trials
- Verastem · 19% recruiting · 21 trials
- Jonsson Comprehensive Cancer Center · 19% recruiting · 321 trials
Related
What to do with this University of Wisconsin, Milwaukee page
21 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Milwaukee or any single study.
- 4 of University of Wisconsin, Milwaukee's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Tic Disorders is the condition University of Wisconsin, Milwaukee studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Tic Disorders trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Wisconsin, Milwaukee pipeline card: 21 registered trials from official public datasets.Report a data error.